Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Application of a Machine Learning-Based Early Recurrence Model for Guiding Adjuvant Chemotherapy Use in Patients with Gallbladder Cancer.

Gut and liver·2026
Same authorSame journal

Outcomes and Prognostic Factors in Hepatopancreatoduodenectomy.

Yonsei medical journal·2026
Same author

Association of computed tomography-derived body composition with surgical and oncologic outcomes in periampullary adenocarcinoma.

Surgical endoscopy·2026
Same author

Impairment of Cerebral Interstitial Fluid Dynamics after Whole-Brain Radiotherapy and Its Association with Leukoencephalopathy Development.

Yonsei medical journal·2026
Same author

The impact of the preoperative value of phase angle in bioelectrical impedance analysis on postoperative complications after pancreaticoduodenectomy.

Annals of hepato-biliary-pancreatic surgery·2026
Same author

Evaluation of feasibility and clinical outcomes of robot-assisted pancreaticoduodenectomy after neoadjuvant treatment for patients with advanced pancreatic ductal adenocarcinoma: a retrospective propensity score-matched cohort study.

Annals of surgical treatment and research·2025
Same journal

The Role of YouTube as an Information Platform for Ovarian Cancer: the Educational Quality and Reliability.

Yonsei medical journal·2026
Same journal

Bone Bridge Effect for the Treatment of Acute Osteoporotic Vertebral Compression Fractures: A Multistrategic Approach Using an Anabolic Agent.

Yonsei medical journal·2026
Same journal

The Risk of Incident Diabetes Mellitus in Relation to Egg Consumption among Working-Aged Korean Adults.

Yonsei medical journal·2026
Same journal

SpyGlass Direct Visualization System: A Cost-Effective Approach Enhancing Nutritional and Immune Recovery in Difficult Bile Duct Stone Management.

Yonsei medical journal·2026
Same journal

Optimizing Antibiotic Use for Urinary Tract Infections: A Qualitative Assessment of Regular Prescribing Practices.

Yonsei medical journal·2026
See all related articles

Related Experiment Video

Updated: Sep 24, 2025

Technical Detail for Robot Assisted Pancreaticoduodenectomy
14:45

Technical Detail for Robot Assisted Pancreaticoduodenectomy

Published on: September 28, 2019

14.8K

Intraoperative Radiotherapy for Resectable Pancreatic Cancer Using a Low-Energy X-Ray Source: Postoperative

Yeona Cho1, Jun Won Kim1, Hyung Sun Kim2

  • 1Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Yonsei Medical Journal
|May 5, 2022
PubMed
Summary
This summary is machine-generated.

Intraoperative radiotherapy (IORT) using a low-energy X-ray source is safe and feasible for pancreatic cancer patients. Early results show promising local control, warranting further investigation for clinical benefits.

Keywords:
Pancreatic neoplasmspostoperative complicationsradiotherapyrecurrencex-ray therapy

More Related Videos

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
13:56

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique

Published on: August 14, 2021

6.5K
Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
08:12

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique

Published on: February 2, 2022

2.1K

Related Experiment Videos

Last Updated: Sep 24, 2025

Technical Detail for Robot Assisted Pancreaticoduodenectomy
14:45

Technical Detail for Robot Assisted Pancreaticoduodenectomy

Published on: September 28, 2019

14.8K
Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
13:56

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique

Published on: August 14, 2021

6.5K
Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
08:12

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique

Published on: February 2, 2022

2.1K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Surgical Oncology

Background:

  • Pancreatic cancer presents significant treatment challenges, necessitating innovative therapeutic approaches.
  • Intraoperative radiotherapy (IORT) is being explored as a potentially effective treatment modality.
  • This study investigates the use of low-energy X-ray IORT in resectable pancreatic cancer.

Purpose of the Study:

  • To evaluate the safety and feasibility of low-energy X-ray intraoperative radiotherapy (IORT) in patients with resectable pancreatic cancer.
  • To assess early treatment outcomes, including local control and recurrence patterns.
  • To determine the tolerability and complication rates associated with IORT in this patient population.

Main Methods:

  • A prospective, single-arm, phase II clinical trial involving 41 patients with resectable pancreatic cancer.
  • Patients received 10 Gy of low-energy X-ray IORT (50 kV) at a 5-mm depth post-resection.
  • Adjuvant gemcitabine-based chemotherapy was administered postoperatively.

Main Results:

  • High rates of R0 resection (75.6%) were achieved.
  • A low incidence of severe postoperative complications (4.9%) was observed.
  • The 1-year local control rate was 76.4%, with a median follow-up of 9 months.

Conclusions:

  • Low-energy X-ray IORT is a well-tolerated and feasible treatment option for resectable pancreatic cancer.
  • Preliminary data suggest potential for improved local control.
  • Further follow-up is required to establish long-term clinical benefits, including overall survival.